New pill tested for debilitating eye condition
NCT ID NCT06467435
Summary
This early-stage study is testing the safety of an oral medication called K9 for people with active Thyroid Eye Disease (TED). Up to 10 patients will take the pill twice daily for up to 24 weeks, with doctors closely monitoring for side effects. The study will also track changes in eye symptoms like dryness, double vision, and bulging to see if the treatment helps.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40506, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.